Terms: = Colorectal cancer AND PAM50 AND Prognosis
5 results:
1. The clinicopathological and prognostic significances of CDC73 expression in breast cancer: A pathological and bioinformatics analysis.
E Y; Xue H; Zhang CY; Zhao MZ; Zheng HC
Histol Histopathol; 2023 Apr; 38(4):453-465. PubMed ID: 36255176
[TBL] [Abstract] [Full Text] [Related]
2. classifieR a flexible interactive cloud-application for functional annotation of cancer transcriptomes.
Quinn GP; Sessler T; Ahmaderaghi B; Lambe S; VanSteenhouse H; Lawler M; Wappett M; Seligmann B; Longley DB; McDade SS
BMC Bioinformatics; 2022 Mar; 23(1):114. PubMed ID: 35361119
[TBL] [Abstract] [Full Text] [Related]
3. Galgo: a bi-objective evolutionary meta-heuristic identifies robust transcriptomic classifiers associated with patient outcome across multiple cancer types.
Guerrero-Gimenez ME; Fernandez-Muñoz JM; Lang BJ; Holton KM; Ciocca DR; Catania CA; Zoppino FCM
Bioinformatics; 2020 Dec; 36(20):5037-5044. PubMed ID: 32638009
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of invasive breast cancer samples using a 12-chemokine gene expression score: correlation with clinical outcomes.
Prabhakaran S; Rizk VT; Ma Z; Cheng CH; Berglund AE; Coppola D; Khalil F; Mulé JJ; Soliman HH
Breast Cancer Res; 2017 Jun; 19(1):71. PubMed ID: 28629479
[TBL] [Abstract] [Full Text] [Related]
5. Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the pam50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Gnant M; Filipits M; Greil R; Stoeger H; Rudas M; Bago-Horvath Z; Mlineritsch B; Kwasny W; Knauer M; Singer C; Jakesz R; Dubsky P; Fitzal F; Bartsch R; Steger G; Balic M; Ressler S; Cowens JW; Storhoff J; Ferree S; Schaper C; Liu S; Fesl C; Nielsen TO;
Ann Oncol; 2014 Feb; 25(2):339-45. PubMed ID: 24347518
[TBL] [Abstract] [Full Text] [Related]
